Recruiting Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN NCT07498335 Conditions Autoimmune Diseases, Berger Disease, Bergers Disease, +20 more Locations Hackensack Meridian Health — Neptune City, New Jersey, United States Cincinnati Childrens Hospital MC — Cincinnati, Ohio, United States University of Oklahoma Health Science Center — Oklahoma City, Oklahoma, United States University of Tennessee Health Science Center- Le Bonheur Research Center — Memphis, Tennessee, United States View more locations Show fewer locations Loading locations... View Trial Details
